Obstetrics/Gynecology General
RSSArticles
-
Researchers Say It Is Time to Drop REMS Restriction on Mifepristone
The risk evaluation and mitigation strategy (REMS) restriction on mifepristone has been burdensome for providers and patients, researchers noted. The REMS restriction exacerbates the stigma around abortion care, which already disproportionately affects communities of color and young people. -
Study Finds No Differences in Pregnancy Plans Between Young Black and White Women
Black and white young women share similar desires to avoid pregnancy and similar pregnancy plans, but Black women were much less likely to be pronatal, advocating for a higher birth rate, than were white women, new research revealed. The unintended pregnancy rate is 2.5 times higher for Black women than for white women, which raises questions about why this difference occurs. -
Research Shows Low-Sensitivity Pregnancy Test Works Well After Medication Abortion
New research shows using a low-sensitivity pregnancy test after a medication abortion is both accurate and safe. The 1,000 mIU/mL low-sensitivity pregnancy test or the five-level multilevel pregnancy test can be used safely without a visit to a provider’s office or clinic. -
New Oral Contraceptive Holds Promise of Few or No Blood Clots, Other Adverse Effects
Recent research has shown that a new combined oral contraceptive has high efficacy, cycle control, and safety, even among a diverse American population that included women with a body mass index of 35 kg/m2. The medication contains estetrol (a novel estrogen) and drospirenone. -
Study: STIs Can Affect State Medicaid Budgets
Screening and treatment of STIs can cost states tens of millions of dollars in Medicaid budgets, but public health activities to prevent STIs can help reduce these costs, according to a new study.
-
Intervention Reduces Positive STI Tests and Increases Condom Use
A culturally tailored intervention for a particularly vulnerable group of Black women has reduced the odds of testing positive for a sexually transmitted infection and increased condom use in vaginal or anal intercourse, the authors of a recent study found.
-
Fewer Tests, Possible Increases in Sexually Transmitted Infections During Pandemic
Public health officials still do not know the full effect of the pandemic on the incidence of sexually transmitted infections (STIs) in the United States. The COVID-19 pandemic disrupted STI testing. It is unknown if people engaged in risky behavior during various regional and national shutdowns.
-
Study: Abortions Do Not Lead to Mental Health Problems
The authors of a new paper noted the reasons why women decide to undergo an abortion include many mental health risk factors, such as poverty, lack of social supports, domestic violence, rape, incest, pre-existing mental illness, and lack of education. But post-abortion, women’s mental health status does not deteriorate, although stress levels might increase if they experience barriers in obtaining the abortion.
-
FDA Makes Medication Abortion Available Via Telehealth
The FDA enabled reproductive health providers to prescribe mifepristone, the abortion medication, via telemedicine — at least through the duration of the pandemic. The FDA approved lifting the requirement of in-person dispensing of mifepristone, since the COVID-19 pandemic presents additional COVID-related risks to patients and healthcare personnel when patients visit a clinic solely to receive a prescription.
-
Biden Administration Proposes New Title X Rule
The U.S. Department of Health and Human Services proposed a new Title X rule to ensure access to quality family planning services. The proposed changes would revise the Trump administration’s 2019 rules that Title X advocates say are harmful to women served by these public health services.